Less Ads, More Data, More Tools Register for FREE

Pin to quick picksERGO.L Regulatory News (ERGO)

  • There is currently no data for ERGO

Director/PDMR Shareholding

25 Jun 2019 07:00

RNS Number : 2659D
Ergomed plc
25 June 2019
 

Ergomed Plc

("Ergomed" or the "Company")

 

PDMR Dealing

 

Ergomed, a company focused on providing specialised services to the pharmaceutical industry, announces that on 24 June 2019, Dr Miroslav Reljanovic, Executive Chairman of the Company, purchased 200,000 ordinary shares of 1 pence each in the Company ("Share(s)") at a price of 303 pence per Share (the "Purchase").

 

Following the Purchase, Dr Reljanovic's holding in the Company is [11,155,767] Shares (representing [23.97] per cent. of the Company's issued share capital).

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Miroslav Reljanovic

2

Reason for the notification

a)

Position/status

Executive Chairman

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ergomed Plc

b)

Legal Entity Identifier

213800BVS8I9VMC1AP84

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 1 pence each

 

 

 GB00BN7ZCY67

b)

Nature of the transaction

Purchase of Shares

c)

Currency

GBP

d)

Price(s) and volume(s)

Price(s)

Volume(s)

303 pence

200,000

e)

Aggregated information

- Aggregated volume

- Price

- Aggregated total

Volume: 200,000 ordinary shares of 1 pence each, purchase price of 303 pence per share

Aggregated: £606,000.00

 

f)

Date of the transaction

24 June 2019

g)

Place of the transaction

London Stock Exchange, AIM

 

 

Enquiries:

 

Ergomed plc

Tel: +44 (0) 1483 402 975

Miroslav Reljanović (Executive Chairman)

Richard Barfield (Chief Financial Officer)

Numis Securities Limited

Tel: +44 (0) 20 7260 1000

Freddie Barnfield (Nominated Adviser)

James Black (Broker)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHMMGZVMDRGLZZ
Date   Source Headline
4th Apr 20227:00 amRNSIssue of Consideration Shares
1st Apr 202211:25 amRNSTotal Voting Rights
29th Mar 20227:00 amRNSErgomed Preliminary Results 2021
9th Mar 20227:00 amRNSJohn Dawson CBE Appointed to Ergomed Board as NED
1st Mar 20227:00 amRNSTotal Voting Rights
28th Feb 20227:00 amRNSErgomed Notice of Preliminary Results
11th Feb 20224:06 pmRNSDirector's Dealing
9th Feb 20227:00 amRNSAcquisition of ADAMAS
2nd Feb 20225:47 pmRNSHolding(s) in Company
25th Jan 20227:00 amRNSErgomed 2021 Trading Update
4th Jan 20227:00 amRNSTotal Voting Rights and Block Listing Return
1st Dec 20217:00 amRNSTotal Voting Rights
25th Nov 20217:00 amRNSExercise of Options
23rd Nov 20211:10 pmRNSHoldings in Company
15th Nov 20217:00 amRNSErgomed to Present at Jefferies Conference 2021
1st Nov 20217:00 amRNSTotal Voting Rights
25th Oct 20217:00 amRNSExercise of Share Options and Total Voting Rights
21st Oct 202110:20 amRNSHolding(s) in Company
5th Oct 20217:10 amEQSErgomed (ERGO): US is now the biggest market in the mix
5th Oct 20217:01 amEQSCreo Medical (CREO): Initiation - Providing energy for endoscopic surgery
1st Oct 20217:00 amRNSTotal Voting Rights
28th Sep 20217:00 amRNSErgomed Interim results
1st Sep 20217:00 amRNSTotal Voting Rights
23rd Aug 20217:00 amRNSNotice of Interim Results
19th Aug 202112:06 pmRNSHolding(s) in Company
18th Aug 202112:24 pmRNSHolding(s) in Company
18th Aug 202112:09 pmRNSDirector dealings
12th Aug 20217:01 amEQSErgomed (ERGO): Momentum continues with EBITDA upgrades
2nd Aug 20217:00 amRNSTotal Voting Rights
27th Jul 20217:00 amRNSTrading Update
19th Jul 20217:00 amRNSAppointment of Joint Corporate Broker
1st Jul 20217:00 amRNSBlock listing Interim Review
1st Jul 20217:00 amRNSTotal Voting Rights
17th Jun 20214:28 pmRNSHolding(s) in Company
17th Jun 20217:05 amRNSBoard Change
14th Jun 20218:14 amEQSErgomed (ERGO): FY21e EBITDA 'materially ahead' of consensus
10th Jun 202110:00 amRNSResult of AGM
10th Jun 20217:00 amRNSAGM Statement
2nd Jun 20218:00 amEQSEdison Investment Research Limited: Ergomed (ERGO): What's next after stellar 2020 performance?
1st Jun 20217:00 amRNSTotal Voting Rights
28th May 20217:00 amRNSErgomed to Present at Jefferies Conference
14th May 202111:30 amRNSHolding(s) in Company
14th May 20217:00 amRNSNotice of AGM and Annual Report
10th May 20217:00 amRNSBoard Changes
4th May 20217:00 amRNSTotal Voting Rights
29th Apr 20214:35 pmRNSPrice Monitoring Extension
29th Apr 20217:00 amRNSBoard Changes
26th Apr 20217:00 amRNSErgomed expands operations in Japan
1st Apr 20217:00 amRNSTotal Voting Rights
23rd Mar 20217:00 amRNSAudited Full Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.